Wednesday, April 16, 2025

Sharp uptake in use of new weight loss and glucose-lowering medications

Researchers found that by December 2023, more than 1 in 3 of the medications being started for type 2 diabetes treatment were GLP-1RA-based medications.

from Top Health News -- ScienceDaily https://ift.tt/eDV8R6n
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Scientists reveal the real benefits and hidden risks of medical cannabis

A sweeping review of more than 2,500 studies reveals that despite booming public enthusiasm, cannabis has strong scientific support for only...